News

The makers of TecentriqⓇ (atezolizumab) and ImfinziⓇ (durvalumab) have announced that they are voluntarily withdrawing both drugs as bladder cancer treatments in the United States.1,2 In 2016, the U.S. Food...

The American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...

Are you an adult with a current or past cancer diagnosis? Are you interested in learning more about your personality? If so, you may be qualified to participate in an...

Pharmaceutical company Merck has announced that it is building a new manufacturing facility so it can significantly expand production of Tice® BCG (BCG live for intravesical use), a drug used...

Arizona State University is seeking sleep-disturbed cancer patients to participate in a research study. The purpose of the research is to determine the effects of an 8-week smartphone-based health intervention...

You may have read some recent research asserting a link between bright outdoor streetlights and colorectal cancer. A Barcelona-based research team found that nighttime exposure to blue spectrum light cast...

As a diagnostic tool to confirm or rule out bladder cancer, the cystoscopy (along with cytology urine tests) have long been considered the gold standard. But cystoscopies are uncomfortable at...

Editor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Learn more in Self-Care in Uncertain Times...

Bladder cancer may soon (and finally) be recognized as a condition caused by exposure to Agent Orange during military service. On July 22, 2020, the U.S. Senate amended the National...

The first half of 2020 has overwhelmed us with an ongoing firehose of big news. In this relentless news climate, it is understandable that news that normally might get more...

In early 2019, news of a shortage of a bladder cancer treatment called BCG started circulating. In this year’s Bladder Cancer In America survey, we asked 589 people with bladder...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

This article was written on March 30, 2020. Further developments in what we know about the Coronavirus are continuously emerging. Learn more in Self-Care in Uncertain Times. The spread of...

The US Food and Drug Administration (FDA) has approved JelmytoTM (mitomycin gel) as the first therapy for treatment of low-grade upper tract urothelial cancer (UTUC).1-2 Urothelial cancer is a cancer...

Worldwide shortages continue to affect the ability of people with non-muscle-invasive bladder cancer (NMIBC) to receive Bacillus Calmette-Guérin (BCG), the gold standard in treatment.1 In the face of the COVID-19...

It is common to feel overwhelmed about COVID-19: so much information changing day-to-day. Here are some of the important COVID-19 stories that may be applicable to people living with one...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...